Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 2Uterine Cervical Dysplasia 1Supratentorial Neoplasms 1Stomach Neoplasms 1Polyposis, Gastric 1Pain, Postoperative 1Mouth Neoplasms 1Hypotension 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Duodenal Neoplasms 1Colonic Neoplasms 1

Interventions

Propofol 3Oxaliplatin 3Morphine 3Fentanyl 3Sevoflurane 2Ropivacaine 2Fluorouracil 2Capecitabine 2Bupivacaine 2Bevacizumab 2Acetaminophen 2polyethylene glycol 3350 1oxycodone-acetaminophen 1gatorade 1fish oil triglycerides 1Vitamin D 1Tranexamic Acid 1Tramadol 1Tegafur 1Sodium Chloride 1Simethicone 1Saline Solution 1Rivaroxaban 1Polyethylene Glycols 1Pirinitramide 1Panitumumab 1Orphenadrine 1Neuroleptanalgesia 1Midazolam 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Colonic Neoplasms × Epinephrine × Clear all
NCT05345613 2026-01-13

Tranexamic Acid During Colonic Endoscopic Resection Procedures

Assaf-Harofeh Medical Center

Phase 4 Recruiting
200 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡